Otezla's Phase 2 trial ended in August 2009 and Celgene reported results on December 15, 2009. That was about 4.5 months.
If we use Otezla’s timeline to estimate Prurisol, the trial ended on December 21, 2017. Let's start the unblinding clock after the New Year. 4.5 months later should be mid-May.
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links